97 related articles for article (PubMed ID: 3481821)
1. Effects of the non-steroidal anti-inflammatory drugs, piroxicam or sulindac, on the antihypertensive actions of propranolol and verapamil.
Baez MA; Alvarez CR; Weidler DJ
J Hypertens Suppl; 1987 Dec; 5(5):S563-6. PubMed ID: 3481821
[TBL] [Abstract][Full Text] [Related]
2. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
[TBL] [Abstract][Full Text] [Related]
3. Effect of Clinoril (sulindac, MSD), piroxicam and placebo on the hypotensive effect of propranolol in patients with mild to moderate essential hypertension.
Ebel DL; Rhymer AR; Stahl E; Tipping R
Scand J Rheumatol Suppl; 1986; 62():41-9. PubMed ID: 3541168
[TBL] [Abstract][Full Text] [Related]
4. Effects of non-steroidal anti-inflammatory drugs on hypertension control using angiotensin converting enzyme inhibitors and thiazide diuretics.
Bhagat K
East Afr Med J; 2001 Oct; 78(10):507-9. PubMed ID: 11921591
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular responses to verapamil and propranolol in hypertensive patients.
McInnes GT; Findlay IN; Murray G; Cleland JG; Dargie HJ
J Hypertens Suppl; 1985 Dec; 3(3):S219-21. PubMed ID: 2856708
[TBL] [Abstract][Full Text] [Related]
6. Propranolol-hydralazine combination in essential hypertension.
Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
8. The effects of indomethacin and sulindac upon the blood pressures of individuals with untreated labile or mild hypertension.
Lewis RV; McLay J; Maclean D; Tregaskis B
J Hum Hypertens; 1989 Aug; 3(4):233-7. PubMed ID: 2677375
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure.
Pope JE; Anderson JJ; Felson DT
Arch Intern Med; 1993 Feb; 153(4):477-84. PubMed ID: 8435027
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK
Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962
[TBL] [Abstract][Full Text] [Related]
12. Interaction between antihypertensives and NSAIDs in primary care: a controlled trial.
Pavlicević I; Kuzmanić M; Rumboldt M; Rumboldt Z
Can J Clin Pharmacol; 2008; 15(3):e372-82. PubMed ID: 18953082
[TBL] [Abstract][Full Text] [Related]
13. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
14. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA; Punzi CF
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
[TBL] [Abstract][Full Text] [Related]
16. [Piroxicam and fentiazac do not change the arterial pressure in hypertensives patients undergoing treatment].
Pacheco D; Roman O; González M; Román M
Rev Med Chil; 1989 Oct; 117(10):1150-3. PubMed ID: 2519359
[TBL] [Abstract][Full Text] [Related]
17. Propranolol-hydrochlorothiazide combination in essential hypertension.
Stevens JD; Mullane JF
Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
[TBL] [Abstract][Full Text] [Related]
18. [Controlled study on the treatment of hypertension with verapamil in retard form].
Belz GG; Spies G
Z Kardiol; 1985 Aug; 74(8):453-9. PubMed ID: 3901562
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the Vital Signs Quality of Life Questionnaire in three studies on hypertension.
Kong BW; Bean JA; Stephens D
J Hum Hypertens; 1995 Apr; 9(4):255-62. PubMed ID: 7595908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
